FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Clinical and diagnostic laboratory immunology1999; 6(5); 696-700; doi: 10.1128/CDLI.6.5.696-700.1999

Detection of borna disease virus-reactive antibodies from patients with psychiatric disorders and from horses by electrochemiluminescence immunoassay.

Abstract: The prevalence of Borna disease virus (BDV)-specific antibodies among patients with psychiatric disorders and healthy individuals has varied in several reports using several different serological assay methods. A reliable and specific method for anti-BDV antibodies needs to be developed to clarify the pathological significance of BDV infections in humans. We developed a new electrochemiluminescence immunoassay (ECLIA) for the antibody to BDV that uses two recombinant proteins of BDV, p40 and p24 (full length). Using this ECLIA, we examined 3,476 serum samples from humans with various diseases and 917 sera from blood donors in Japan for the presence of anti-BDV antibodies. By ECLIA, 26 (3.08%) of 845 schizophrenia patients and 9 (3.59%) of 251 patients with mood disorders were seropositive for BDV. Among 323 patients with other psychiatric diseases, 114 with neurological diseases, 75 with chronic fatigue syndrome, 85 human immunodeficiency virus-infected patients, 50 with autoimmune diseases including rheumatoid arthritis and systemic lupus erythematosis and 17 with leprosy, there was no positive case except one case each with alcohol addiction, AIDS, and dementia. Although 19 (1.36%) of 1,393 patients with various ocular diseases, 10 (1.09%) of 917 blood donors, and 3 (4.55%) of 66 multitransfused patients were seropositive for BDV-specific antigen, high levels of seroprevalence in schizophrenia patients and young patients (16 to 59 years old) with mood disorders were statistically significant. The immunoreactivity of seropositive sera could be verified for specificity by blocking with soluble p40 and/or p24 recombinant protein. Anti-p24 antibody was more frequent than p40 antibody in most cases, and in some psychotic patients antibody profiles showed only p40 antibody. Although serum positive for both p40 and p24 antibodies was not found in this study, the p40 ECLIA count in schizophrenia patients was higher than that of blood donors. Furthermore, we examined 90 sera from Japanese feral horses. Antibody profiles of control human samples are similar to that of naturally BDV-infected feral horses. We concluded that BDV infection was associated in some way with psychiatric disorders.
Get Full Text
Publication Date: 1999-09-03 PubMed ID: 10473520PubMed Central: PMC95757DOI: 10.1128/CDLI.6.5.696-700.1999Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores the prevalence of Borna disease virus (BDV)-specific antibodies in patients with psychiatric disorders, compared to healthy individuals, via a novel electrochemiluminescence immunoassay (ECLIA). The study’s findings indicate a significantly higher rate of BDV antibodies in individuals with schizophrenia and younger patients with mood disorders, suggesting a potential link between BDV infection and certain psychiatric conditions.

Introduction and Methodology

  • The study began with the researchers noting a variance in the reporting of BDV-specific antibodies among patients with psychiatric disorders and healthy individuals. This led them to devise a more reliable method to evaluate BDV antibodies in humans and its possible pathological significance.
  • The researchers developed a new electrochemiluminescence immunoassay (ECLIA) to assess the presence of antibody to BDV. This test utilized two recombinant proteins of BDV, p40 and p24.
  • A large sample of serum samples from humans with various diseases (3,476) and from blood donors (917) were tested using ECLIA.

Results and Findings

  • Out of the 845 schizophrenia patients tested, 26 (3.08%) were found to be seropositive for BDV. Similarly, 3.59% of patients with mood disorders were seropositive for BDV. Except for one case each of alcohol addiction, AIDS, and dementia, no cases were positive in patients with other psychiatric diseases, neurological diseases, chronic fatigue syndrome, HIV infection, autoimmune diseases, and leprosy.
  • Compared to the lower seroprevalence rates among patients with ocular diseases (1.36%), blood donors (1.09%), and multitransfused patients (4.55%), the higher levels of BDV antibodies in schizophrenia patients and young patients with mood disorders were statistically significant.
  • The specificity of immunoreactivity of seropositive sera was verified through blocking with soluble p40 or p24 recombinant protein. Anti-p24 antibody was more common than p40 antibody in most cases. However, only p40 antibody was found in some psychotic patients.
  • The study also examined sera from Japanese feral horses (90 samples) and found antibody profiles similar to control human samples, indicating a similarity between BDV infection in humans and horses.

Conclusion

  • The research concluded that there seems to be an association between BDV infection and certain psychiatric disorders, given the higher seroprevalence found in patients with schizophrenia and younger patients with mood disorders.

Cite This Article

APA
Yamaguchi K, Sawada T, Naraki T, Igata-Yi R, Shiraki H, Horii Y, Ishii T, Ikeda K, Asou N, Okabe H, Mochizuki M, Takahashi K, Yamada S, Kubo K, Yashiki S, Waltrip RW, Carbone KM. (1999). Detection of borna disease virus-reactive antibodies from patients with psychiatric disorders and from horses by electrochemiluminescence immunoassay. Clin Diagn Lab Immunol, 6(5), 696-700. https://doi.org/10.1128/CDLI.6.5.696-700.1999

Publication

Clinical and diagnostic laboratory immunology
ISSN: 1071-412X
NlmUniqueID: 9421292
Country: United States
Language: English
Volume: 6
Issue: 5
Pages: 696-700

Researcher Affiliations

Yamaguchi, K
  • Blood Transfusion Service and Internal Medicine, Kumamoto University School of Medicine, Kumamoto, Japan. kyama@gpo.kumamoto-u.ac.jp
Sawada, T
    Naraki, T
      Igata-Yi, R
        Shiraki, H
          Horii, Y
            Ishii, T
              Ikeda, K
                Asou, N
                  Okabe, H
                    Mochizuki, M
                      Takahashi, K
                        Yamada, S
                          Kubo, K
                            Yashiki, S
                              Waltrip, R W
                                Carbone, K M

                                  MeSH Terms

                                  • Age Distribution
                                  • Animals
                                  • Animals, Wild
                                  • Antibodies, Viral / analysis
                                  • Borna Disease / epidemiology
                                  • Borna Disease / immunology
                                  • Borna disease virus
                                  • Horses
                                  • Humans
                                  • Immunoassay / methods
                                  • Luminescent Measurements
                                  • Male
                                  • Mass Screening / methods
                                  • Mood Disorders / immunology
                                  • Mood Disorders / virology
                                  • Recombinant Proteins / immunology
                                  • Schizophrenia / immunology
                                  • Schizophrenia / virology
                                  • Sensitivity and Specificity
                                  • Seroepidemiologic Studies
                                  • Sex Distribution

                                  References

                                  This article includes 26 references
                                  1. Amsterdam JD, Winokur A, Dyson W, Herzog S, Gonzalez F, Rott R, Koprowski H. Borna disease virus. A possible etiologic factor in human affective disorders?. Arch Gen Psychiatry 1985 Nov;42(11):1093-6.
                                    pubmed: 3931604doi: 10.1001/archpsyc.1985.01790340077011google scholar: lookup
                                  2. Auwanit W, Ayuthaya PI, Nakaya T, Fujiwara S, Kurata T, Yamanishi K, Ikuta K. Unusually high seroprevalence of Borna disease virus in clade E human immunodeficiency virus type 1-infected patients with sexually transmitted diseases in Thailand.. Clin Diagn Lab Immunol 1996 Sep;3(5):590-3.
                                    pmc: PMC170412pubmed: 8877141doi: 10.1128/cdli.3.5.590-593.1996google scholar: lookup
                                  3. Blackburn GF, Shah HP, Kenten JH, Leland J, Kamin RA, Link J, Peterman J, Powell MJ, Shah A, Talley DB. Electrochemiluminescence detection for development of immunoassays and DNA probe assays for clinical diagnostics.. Clin Chem 1991 Sep;37(9):1534-9.
                                    pubmed: 1716534
                                  4. Bode L. Human infections with Borna disease virus and potential pathogenic implications.. Curr Top Microbiol Immunol 1995;190:103-30.
                                    pubmed: 7789147doi: 10.1007/978-3-642-78618-1_7google scholar: lookup
                                  5. Bode L, Zimmermann W, Ferszt R, Steinbach F, Ludwig H. Borna disease virus genome transcribed and expressed in psychiatric patients.. Nat Med 1995 Mar;1(3):232-6.
                                    pubmed: 7585039doi: 10.1038/nm0395-232google scholar: lookup
                                  6. Briese T, Schneemann A, Lewis AJ, Park YS, Kim S, Ludwig H, Lipkin WI. Genomic organization of Borna disease virus.. Proc Natl Acad Sci U S A 1994 May 10;91(10):4362-6.
                                    pmc: PMC43785pubmed: 8183914doi: 10.1073/pnas.91.10.4362google scholar: lookup
                                  7. Cubitt B, de la Torre JC. Borna disease virus (BDV), a nonsegmented RNA virus, replicates in the nuclei of infected cells where infectious BDV ribonucleoproteins are present.. J Virol 1994 Mar;68(3):1371-81.
                                    pmc: PMC236591pubmed: 8107202doi: 10.1128/JVI.68.3.1371-1381.1994google scholar: lookup
                                  8. De La Torre JC, Gonzalez-Dunia D, Cubitt B, Mallory M, Mueller-Lantzsch N, Grässer FA, Hansen LA, Masliah E. Detection of borna disease virus antigen and RNA in human autopsy brain samples from neuropsychiatric patients.. Virology 1996 Sep 15;223(2):272-82.
                                    pubmed: 8806563doi: 10.1006/viro.1996.0479google scholar: lookup
                                  9. de la Torre JC, Bode L, Dürrwald R, Cubitt B, Ludwig H. Sequence characterization of human Borna disease virus.. Virus Res 1996 Sep;44(1):33-44.
                                    pubmed: 8873411doi: 10.1016/0168-1702(96)01338-xgoogle scholar: lookup
                                  10. Fu ZF, Amsterdam JD, Kao M, Shankar V, Koprowski H, Dietzschold B. Detection of Borna disease virus-reactive antibodies from patients with affective disorders by western immunoblot technique.. J Affect Disord 1993 Jan;27(1):61-8.
                                    pubmed: 8432962doi: 10.1016/0165-0327(93)90098-5google scholar: lookup
                                  11. Horimoto T, Takahashi H, Sakaguchi M, Horikoshi K, Iritani S, Kazamatsuri H, Ikeda K, Tashiro M. A reverse-type sandwich enzyme-linked immunosorbent assay for detecting antibodies to Borna disease virus.. J Clin Microbiol 1997 Jul;35(7):1661-6.
                                    pmc: PMC229817pubmed: 9196169doi: 10.1128/jcm.35.7.1661-1666.1997google scholar: lookup
                                  12. Kao M, Hamir AN, Rupprecht CE, Fu ZF, Shankar V, Koprowski H, Dietzschold B. Detection of antibodies against Borna disease virus in sera and cerebrospinal fluid of horses in the USA.. Vet Rec 1993 Mar 6;132(10):241-4.
                                    pubmed: 8460459doi: 10.1136/vr.132.10.241google scholar: lookup
                                  13. Lipkin WI, Schneemann A, Solbrig MV. Borna disease virus: implications for human neuropsychiatric illness.. Trends Microbiol 1995 Feb;3(2):64-9.
                                    pubmed: 7728387doi: 10.1016/s0966-842x(00)88877-0google scholar: lookup
                                  14. Nakamura Y, Kishi M, Nakaya T, Asahi S, Tanaka H, Sentsui H, Ikeda K, Ikuta K. Demonstration of Borna disease virus RNA in peripheral blood mononuclear cells from healthy horses in Japan.. Vaccine 1995 Aug;13(12):1076-9.
                                    pubmed: 7491814doi: 10.1016/0264-410x(95)00050-bgoogle scholar: lookup
                                  15. Nakaya T, Takahashi H, Nakamura Y, Asahi S, Tobiume M, Kuratsune H, Kitani T, Yamanishi K, Ikuta K. Demonstration of Borna disease virus RNA in peripheral blood mononuclear cells derived from Japanese patients with chronic fatigue syndrome.. FEBS Lett 1996 Jan 8;378(2):145-9.
                                    pubmed: 8549821doi: 10.1016/0014-5793(95)01439-xgoogle scholar: lookup
                                  16. Planz O, Stitz L. Borna disease virus nucleoprotein (p40) is a major target for CD8(+)-T-cell-mediated immune response.. J Virol 1999 Feb;73(2):1715-8.
                                    pmc: PMC104005pubmed: 9882386doi: 10.1128/JVI.73.2.1715-1718.1999google scholar: lookup
                                  17. Richt JA, VandeWoude S, Zink MC, Clements JE, Herzog S, Stitz L, Rott R, Narayan O. Infection with Borna disease virus: molecular and immunobiological characterization of the agent.. Clin Infect Dis 1992 Jun;14(6):1240-50.
                                    pmc: PMC7109702pubmed: 1623080doi: 10.1093/clinids/14.6.1240google scholar: lookup
                                  18. Richt JA, Alexander RC, Herzog S, Hooper DC, Kean R, Spitsin S, Bechter K, Schüttler R, Feldmann H, Heiske A, Fu ZF, Dietzschold B, Rott R, Koprowski H. Failure to detect Borna disease virus infection in peripheral blood leukocytes from humans with psychiatric disorders.. J Neurovirol 1997 Apr;3(2):174-8.
                                    pubmed: 9111180doi: 10.3109/13550289709015807google scholar: lookup
                                  19. Rott R, Herzog S, Fleischer B, Winokur A, Amsterdam J, Dyson W, Koprowski H. Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders.. Science 1985 May 10;228(4700):755-6.
                                    pubmed: 3922055doi: 10.1126/science.3922055google scholar: lookup
                                  20. Rott R, Herzog S, Bechter K, Frese K. Borna disease, a possible hazard for man?. Arch Virol 1991;118(3-4):143-9.
                                    pubmed: 2069502doi: 10.1007/BF01314025google scholar: lookup
                                  21. Rubin SA, Waltrip RW 2nd, Bautista JR, Carbone KM. Borna disease virus in mice: host-specific differences in disease expression.. J Virol 1993 Jan;67(1):548-52.
                                    pmc: PMC237392pubmed: 8416380doi: 10.1128/JVI.67.1.548-552.1993google scholar: lookup
                                  22. Sauder C, Müller A, Cubitt B, Mayer J, Steinmetz J, Trabert W, Ziegler B, Wanke K, Mueller-Lantzsch N, de la Torre JC, Grässer FA. Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of human blood-derived BDV RNA.. J Virol 1996 Nov;70(11):7713-24.
                                    pmc: PMC190841pubmed: 8892892doi: 10.1128/JVI.70.11.7713-7724.1996google scholar: lookup
                                  23. Sierra-Honigmann AM, Rubin SA, Estafanous MG, Yolken RH, Carbone KM. Borna disease virus in peripheral blood mononuclear and bone marrow cells of neonatally and chronically infected rats.. J Neuroimmunol 1993 Jun;45(1-2):31-6.
                                    pubmed: 8331163doi: 10.1016/0165-5728(93)90160-zgoogle scholar: lookup
                                  24. Waltrip RW 2nd, Buchanan RW, Carpenter WT Jr, Kirkpatrick B, Summerfelt A, Breier A, Rubin SA, Carbone KM. Borna disease virus antibodies and the deficit syndrome of schizophrenia.. Schizophr Res 1997 Feb 28;23(3):253-7.
                                    pubmed: 9075304doi: 10.1016/s0920-9964(96)00114-4google scholar: lookup
                                  25. Waltrip RW 2nd, Buchanan RW, Summerfelt A, Breier A, Carpenter WT Jr, Bryant NL, Rubin SA, Carbone KM. Borna disease virus and schizophrenia.. Psychiatry Res 1995 Jan 31;56(1):33-44.
                                    pubmed: 7792340doi: 10.1016/0165-1781(94)02600-ngoogle scholar: lookup
                                  26. Yamaguchi K, Sawada T, Yamane S, Haga S, Ikeda K, Igata-Yi R, Yoshiki K, Matsuoka M, Okabe H, Horii Y, Nawa Y, Waltrip RW 2nd, Carbone KM. Synthetic peptide-based electrochemiluminescence immunoassay for anti-Borna disease virus p40 and p24 antibodies in rat and horse serum.. Ann Clin Biochem 2001 Jul;38(Pt 4):348-55.
                                    pubmed: 11471876doi: 10.1258/0004563011900867google scholar: lookup

                                  Citations

                                  This article has been cited 13 times.
                                  1. Shatizadeh-Malekshahi S, Ahmadkhaniha HR, Kiani SJ, Nejati A, Janani L, Yavarian J. No molecular evidence of Borna disease virus among schizophrenia and bipolar disorder patients in Iran. Iran J Microbiol 2017 Apr;9(2):112-118.
                                    pubmed: 29214003
                                  2. Mazaheri-Tehrani E, Maghsoudi N, Shams J, Soori H, Atashi H, Motamedi F, Bode L, Ludwig H. Borna disease virus (BDV) infection in psychiatric patients and healthy controls in Iran. Virol J 2014 Sep 3;11:161.
                                    doi: 10.1186/1743-422X-11-161pubmed: 25186971google scholar: lookup
                                  3. Zhang L, Xu MM, Zeng L, Liu S, Liu X, Wang X, Li D, Huang RZ, Zhao LB, Zhan QL, Zhu D, Zhang YY, Xu P, Xie P. Evidence for Borna disease virus infection in neuropsychiatric patients in three western China provinces. Eur J Clin Microbiol Infect Dis 2014 Apr;33(4):621-7.
                                    doi: 10.1007/s10096-013-1996-4pubmed: 24170181google scholar: lookup
                                  4. Sperner-Unterweger B. Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications. Drugs 2005;65(11):1493-520.
                                    doi: 10.2165/00003495-200565110-00004pubmed: 16033289google scholar: lookup
                                  5. Matsunaga H, Tanaka S, Sasao F, Nishino Y, Takeda M, Tomonaga K, Ikuta K, Amino N. Detection by radioligand assay of antibodies against Borna disease virus in patients with various psychiatric disorders. Clin Diagn Lab Immunol 2005 May;12(5):671-6.
                                    doi: 10.1128/CDLI.12.5.671-676.2005pubmed: 15879032google scholar: lookup
                                  6. Bode L, Ludwig H. Borna disease virus infection, a human mental-health risk. Clin Microbiol Rev 2003 Jul;16(3):534-45.
                                    doi: 10.1128/CMR.16.3.534-545.2003pubmed: 12857781google scholar: lookup
                                  7. Hornig M, Briese T, Lipkin WI. Borna disease virus. J Neurovirol 2003 Apr;9(2):259-73.
                                    doi: 10.1080/13550280390194064pubmed: 12707857google scholar: lookup
                                  8. Marcotte ER, Pearson DM, Srivastava LK. Animal models of schizophrenia: a critical review. J Psychiatry Neurosci 2001 Nov;26(5):395-410.
                                    pubmed: 11762207
                                  9. Carbone KM. Borna disease virus and human disease. Clin Microbiol Rev 2001 Jul;14(3):513-27.
                                    doi: 10.1128/CMR.14.3.513-527.2001pubmed: 11432811google scholar: lookup
                                  10. Jordan I, Lipkin WI. Borna disease virus. Rev Med Virol 2001 Jan-Feb;11(1):37-57.
                                    doi: 10.1002/rmv.300pubmed: 11241801google scholar: lookup
                                  11. Fukuda K, Takahashi K, Iwata Y, Mori N, Gonda K, Ogawa T, Osonoe K, Sato M, Ogata S, Horimoto T, Sawada T, Tashiro M, Yamaguchi K, Niwa S, Shigeta S. Immunological and PCR analyses for Borna disease virus in psychiatric patients and blood donors in Japan. J Clin Microbiol 2001 Feb;39(2):419-29.
                                    doi: 10.1128/JCM.39.2.419-429.2001pubmed: 11158085google scholar: lookup
                                  12. Sighencea MG, Trifu SC. Unravelling the Viral Hypothesis of Schizophrenia: A Comprehensive Review of Mechanisms and Evidence. Int J Mol Sci 2025 Aug 1;26(15).
                                    doi: 10.3390/ijms26157429pubmed: 40806558google scholar: lookup
                                  13. Lee S, No JG, Choi BH, Kim DK, Hyung N, Park J, Choi MK, Yeom DH, Ji J, Kim DH, Yoo JG. Application of Enzyme-Linked Fluorescence Assay (ELFA) to Obtain In Vivo Matured Dog Oocytes through the Assessment of Progesterone Level. Animals (Basel) 2023 Jun 5;13(11).
                                    doi: 10.3390/ani13111885pubmed: 37889804google scholar: lookup
                                  Subscribe to our newsletter
                                  Join 99,658 horse owners like you who receive our email updates on horse health and nutrition.